Accendra Health Adopts Tax Asset Preservation Plan, Declares Preferred Share Rights Dividend
Accendra Health's board adopted a Section 382 rights plan to protect its net operating losses, declaring a dividend of preferred share purchase rights for shareholders of record on Aug. 20, 2026.
What happened
Accendra Health, Inc. (NYSE: ACH), a Virginia-based wholesale medical, dental and hospital equipment supplier, filed a Form 8-K on August 10, 2026, announcing that its board of directors adopted a "Tax Asset Preservation Plan" under Section 382 of the Internal Revenue Code. The plan is designed to protect the company's net operating losses (NOLs) and other tax attributes from being substantially limited by an "ownership change."
As part of the plan, the board declared a dividend of one preferred share purchase right (a "Right") for each share of common stock outstanding on the record date of August 20, 2026. Each Right entitles the holder to purchase one one-thousandth of a share of newly designated Series C Cumulative Preferred Stock at a price of $15.00 per Right, subject to adjustment. The Rights will initially trade attached to the common shares and will separate only if a person or group acquires beneficial ownership of 4.9% or more of the outstanding common shares (becoming an "Acquiring Person").
The plan also includes provisions for a "flip-in" event, under which Rights become exercisable for common shares worth two times the exercise price if an Acquiring Person triggers the plan. The board may also exchange Rights for common shares at one share per Right, or redeem the Rights for $0.001 each at any time before the tenth day after a stock acquisition date, subject to certain conditions. The Rights expire on August 10, 2029, unless the board determines earlier that the NOLs have been fully utilized or are no longer necessary.
The filing also notes that the board approved Articles of Amendment designating the Series C Cumulative Preferred Stock, filed with the Virginia Secretary of State. The stock closed at $1.215 on August 10, down 13.21% from the previous close of $1.40, though the filing does not explain the price movement.
Why it matters
Accendra Health is a small-cap company with significant net operating losses. An ownership change under Section 382 occurs when the percentage of stock owned by certain "5-percent shareholders" increases by more than 50 percentage points over a three-year period. If that happens, the company's ability to use its NOLs to offset future taxable income would be substantially limited, reducing the value of those tax assets.
The rights plan is a common anti-takeover measure, often called a "poison pill." By making it costly for any single shareholder to accumulate a 4.9% stake without board approval, the plan discourages acquisitions that could trigger an ownership change. The low threshold (4.9%) is typical for NOL preservation plans, and the plan grandfathers existing shareholders who already own 4.9% or more, provided they do not increase their stake.
The Rights are not immediately exercisable and do not confer voting or dividend rights until they separate from the common shares. This is a proactive step by the board to protect the company's tax assets, which could be valuable for offsetting future income. The filing does not indicate any activist investor or imminent takeover attempt; it appears to be a defensive measure.
What this means
A Form 8-K is a current report that companies file with the SEC to announce major events that shareholders should know about. Items 1.01, 3.03, 5.03, and 7.01 correspond to entry into a material agreement, modification of security holder rights, amendments to charter/bylaws, and Regulation FD disclosure, respectively. The company also attached the full rights plan as an exhibit.
A "Rights Agreement" is a type of shareholder rights plan, often referred to as a "poison pill." It gives existing shareholders the right to buy additional shares at a discount if any one investor accumulates a threshold stake, diluting the acquirer's ownership. Here, the threshold is 4.9%, and the Rights become exercisable only after an Acquiring Person crosses that threshold, triggering a "Distribution Date." The flip-in provision—where Rights can be exercised for shares worth twice the exercise price—makes it financially punitive for an acquirer.
The Series C Cumulative Preferred Stock is a new class of preferred shares created solely for the rights plan. Each one-thousandth of a preferred share has the same dividend and liquidation rights as one common share, so the Rights are economically similar to common stock if exercised. The board can redeem the Rights for a nominal amount ($0.001) before they trigger, which is standard for such plans, allowing the board to cancel the plan if a takeover threat passes.
Normally, after adopting a rights plan, the company issues the Rights dividend, and the common stock continues to trade with the Rights attached. Unless a shareholder acquires 4.9% or more, the Rights will never separate or become exercisable. The plan is set to expire in three years, after which the NOLs may be fully utilized or the risk of ownership change may have passed.
Sources
- 8-K filed 2026-08-10
- Daily price history
Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.